Ear wiggling tics: treatment with botulinum toxin injection

Srirompotong, Supaporn; Saeseow, Patchareeporn; Kharmwan, Samerduan; Srirompotong, Somchai

doi:10.1007/s00405-006-0200-1

Cited by 15 publications

(12 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Initially, botulinum toxin injection was used for selected severe cases [3, 107, 125, 229]. Other case reports and case series followed also including children after the age of 8 years [4, 131, 215, 257, 273, 279]. In 35 of 186 patients, botulinum toxin injections were effectively controlling motor tics [8].…”

Section: Pharmacological Treatment Options For Tsmentioning

confidence: 99%

European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment

Roessner¹,

Plessen²,

Rothenberger³

et al. 2011

Eur Child Adolesc Psychiatry

389

398

View full text Add to dashboard Cite

To develop a European guideline on pharmacologic treatment of Tourette syndrome (TS) the available literature was thoroughly screened and extensively discussed by a working group of the European Society for the Study of Tourette syndrome (ESSTS). Although there are many more studies on pharmacotherapy of TS than on behavioral treatment options, only a limited number of studies meets rigorous quality criteria. Therefore, we have devised a two-stage approach. First, we present the highest level of evidence by reporting the findings of existing Cochrane reviews in this field. Subsequently, we provide the first comprehensive overview of all reports on pharmacological treatment options for TS through a MEDLINE, PubMed, and EMBASE search for all studies that document the effect of pharmacological treatment of TS and other tic disorders between 1970 and November 2010. We present a summary of the current consensus on pharmacological treatment options for TS in Europe to guide the clinician in daily practice. This summary is, however, rather a status quo of a clinically helpful but merely low evidence guideline, mainly driven by expert experience and opinion, since rigorous experimental studies are scarce.

show abstract

Section: Pharmacological Treatment Options For Tsmentioning

confidence: 99%

European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment

Roessner¹,

Plessen²,

Rothenberger³

et al. 2011

Eur Child Adolesc Psychiatry

389

398

View full text Add to dashboard Cite

show abstract

“…The current literature on the use of BONT in managing tic disorders is limited to a handful of case reports 6,7 or case series 8,9 and a single small randomised control trial 10 . These studies have addressed patients with vocal tics, ear-wiggling tics or tics of the neck muscles that were idiopathic in nature or associated with Tourette's syndrome.…”

Section: Discussionmentioning

confidence: 99%

Botulinum Toxin to Control an Incapacitating Tic in a Child with a Clavicular Fracture

Chen

Thalayasingam

2010

Anaesth Intensive Care

View full text Add to dashboard Cite

We present the case of an 11-year-old boy who suffered from an undefined tic disorder and incidentally sustained a traumatic fracture of the clavicle. The fracture healing course was complicated by the tic activity, and the frequency and intensity of the tics were worsened by the presence of clavicular pain. He underwent surgery and his management required the collaboration of orthopaedic surgeons, the Acute Pain Service, neurologists for tic management and rehabilitation physicians who performed the intramuscular injections of botulinum toxin. We recommend a multidisciplinary and multimodal approach to managing patients suffering from tic disorders and highlight the consideration of intramuscular injections of botulinum toxin, which were successful for this patient.

show abstract

“…These muscles have been considered vestigial in humans, though it has been suggested that during development in the womb they may exert forces on the cartilage and affect the shaping of the ear ( 2 , 3 ). In postnatal humans, they are rarely under voluntary control ( 2 , 4 ). However, the neural connections of the auricular muscles with the brainstem and other deep brain structures are intact ( 5 – 7 ), and these muscles are easily accessible for wearable neuroprosthetics.…”

Section: Introductionmentioning

confidence: 99%

Neuroprosthetics for Auricular Muscles: Neural Networks and Clinical Aspects

2018

View full text Add to dashboard Cite

The mammalian external ear houses extrinsic and intrinsic auricular muscles. There are three extrinsic auricular muscles—the posterior, superior, and anterior auricular muscles—and six intrinsic muscles—the helicis major and minor, tragicus, anti-tragicus, transverse and oblique muscles. These muscles have been considered vestigial in humans. However, numerous therapeutic and diagnostic wearable devices are designed to monitor and alleviate the symptoms of neurological disorders, brainstem injuries, emotional states, and auditory functions, by making use of the neural networks of the auricular muscles and their locations, which are easily accessible for ergonomic wearable biomedical devices. They can also serve as a bio-controller of human neuroprosthetics. The functionality of these auricular muscles remains elusive and requires further experimentation for a more in-depth understanding of their anatomy. The aims of this review are (1) to provide a detailed account of the neural networks of the extrinsic and intrinsic auricular muscles, (2) to describe diagnostic and therapeutic functions of these muscles as demonstrated in the current literature, and (3) to outline existing and potential neuroprosthetic applications making use of the auricular muscles and their neural networks.

show abstract

Ear wiggling tics: treatment with botulinum toxin injection

Cited by 15 publications

References 3 publications

European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment

European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment

Botulinum Toxin to Control an Incapacitating Tic in a Child with a Clavicular Fracture

Neuroprosthetics for Auricular Muscles: Neural Networks and Clinical Aspects

Contact Info

Product

Resources

About